AstraZeneca Shares Soar on Pfizer Interest

LONDON -- AstraZeneca (AZN) shares have jumped 15 percent in early trading after Pfizer (PFE) publicly disclosed details of a $100 billion bid approach.

PfiZer, the maker of Viagra, said Monday that AstraZeneca rejected an initial approach in January valuing the company at about 59 billion pounds ($100 billion). The cash and shares deal would represent a 30% premium on AstraZeneca's closing share price of 35.26 pounds on Jan. 3, the date of the offer.

Pfizer remains interested and is confident a combination is possible.

 

Copyright 2014 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

If you liked this article you might like

Dow, S&P 500 Set New Records as Fed Moves to Unwind Balance Sheet

Stocks In Negative Territory as Chances for December Hike Surge

The Wait for 'Milestone' Fed Meeting Keeps Stocks in Flux

The 6 Medications Being Used to Tackle the Opioid Epidemic